Observational studyMedicine2025
Diagnostic performance of ultrasonography for evaluating subclinical atherosclerosis in alopecia areata patients without risk factors for cardiovascular diseases.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to evaluate the risk of atherosclerosis and cardiovascular disease (CVD) in patients with alopecia areata (AA) by the measurement of carotid artery intima-media thickness (CIMT) with Doppler ultrasonography. Seventy six subjects with AA were compared prospectively with age and sex-matched healthy 76 subjects. Individuals in both groups were aged between 18 and 42, had a body mass index <30 kg/m2, and had no risk factors for CVDs. CIMT in both sides was assessed by Doppler ultrasonography, and mean values were noted. CIMT in both sides was significantly higher in patients with AA than healthy control group (P < .05). AA patients were divided into subgroups according to AA type, disease duration, disease severity, and existence of poor prognostic factors. CIMT did not show statistically significant difference between AA subgroups (P > .05), but it was higher in AA patients with poor prognostic factors. High CIMT values as an indicator of subclinical atherosclerosis may show the risk of CVDs in patients with AA. CIMT can be easily measured by ultrasonography which is an accessible, fast, and radiation-free radiological method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.